6 Recruiting Studies Using Resmetirom
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Resmetirom
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)
📍 University of Alabama at Birmingham (UAB) — Birmingham, Alabama
NASH
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)
📍 Central Research Associates — Birmingham, Alabama
Non-Alcoholic Fatty Liver Disease
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Resmetirom in Children and Adolescents With MASH
📍 Riley Hospital for Children at IU Health — Indianapolis, Indiana
MASH
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase4 💊 Investigational Drug / Biologic
Nutrition Intervention Combined With Resmetirom for MASH
📍 CUNY Graduate School of Public Health and Health Policy — New York, New York
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
📍 University of California San Diego — La Jolla, California
MASH - Metabolic Dysfunction-Associated Steatohepatitis
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
📍 University of Alabama Birmingham — Birmingham, Alabama
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
View Study & Checklist ➔